You have read all your free articles, to continue reading subscribe to read the rest of this content.
Finnish Combinostics has announced the closure of a €3.9 million series A funding round that will see the company scale its platform for early-stage Alzheimer’s diagnosis to the US and Asia. The round was jointly-led by Industrifonden and NordicNinja VC, with Combinostics representing NordicNAlready a subscriber Login You have read…
The Swedish medtech company has initiated a collaboration within cardiac disease with the pharma company Bayer AB. The aim with the collaboration is to bring treatment to more people suffering from heart disease and hence, avoid stroke and heart attack. They believe that by introducing a new digiAlready a subscriber…
Elekta has signed a non-binding Memorandum of Understanding with ViewRay to advance the knowledge and application of MR-guided radiation therapy. In connection with the collaboration, Elekta has committed to make an investment in ViewRay representing approximately 9.9 percent of the shares of VieAlready a subscriber Login You have read all…
The company receives close to 1 million SEK in a research grant from Swedish innovation agency, Vinnova, for developing a new treatment for genetic mitochondrial diseases. NeuroVive receives the grant from Vinnova's 2017 Swelife call to continue progressing the preclinical project NVP015. The cutAlready a subscriber Login You have read…
